Full-Time

Inpatient Speech Pathologist

Updated on 9/3/2026

Brown University Health

Brown University Health

1-10 employees

Remote behavioral health care platform analytics

Compensation Overview

$35.90 - $59.23/hr

Providence, RI, USA

In Person

Master's

Category
Medical, Clinical & Veterinary (1)

Get referred to Brown University Health

See people who can refer or advise you

Requirements
  • A Master's degree in Speech-Language Pathology from an accredited institution is required.
  • A Rhode Island state license issued by the Rhode Island Department of Health, or a provisional Rhode Island state license for Clinical Fellows participating in a supervised clinical fellowship year, is required.
  • A Certificate of Clinical Competence from the American Speech-Language-Hearing Association is required; Clinical Fellows must provide evidence of pursuing ASHA certification.
  • One to two years of experience or eligibility for a provisional Rhode Island license is required; Clinical Fellows will be considered.
  • The employee must be fit for duty in accordance with OSHA standards and program-specific needs.
Responsibilities
  • Provide clinical services including screening, assessment, diagnosis, intervention, management, counseling and education, documentation, and referral for inpatients and outpatients with speech, voice, feeding, swallowing, language, and cognitive impairments.
  • Demonstrate effective and professional verbal and non-verbal communication with patients, caregivers, rehabilitation staff, providers, and other healthcare professionals.
  • Communicate proactively and adjust communication and responses to the listener's level of understanding.
  • Evaluate speech, voice, language, feeding and swallowing, and cognitive impairments.
  • Establish diagnoses, prognoses, and individualized plans of care.
  • Implement treatment interventions based on plans of care while considering precautions, indications, and contraindications.
  • Direct and coordinate patients' rehabilitation plans of care.
  • Evaluate patient progress and revise goals and plans of care accordingly.
  • Educate and train patients and caregivers.
  • Anticipate and communicate discharge, home-care needs, and available resources.
  • Complete documentation and charges accurately and on time in compliance with department policy.
  • Complete clinical documentation reflecting eligibility and medical necessity of services in compliance with professional and regulatory standards.
  • Apply evidence-based practice to all aspects of clinical care.
  • Seek additional guidance when necessary to provide safe and effective patient care.
  • Recommend and refer patients for additional diagnostic testing or services.
  • Develop, select, and prescribe multimodal augmentative and alternative communication systems, including unaided strategies such as manual signs and gestures and aided strategies such as speech-generating devices, manual communication boards, and picture schedules.
  • Select, fit, and establish effective use of prosthetic and adaptive devices for communication and swallowing, including electrolarynges and speaking valves.
  • Use instrumental technology to diagnose and treat communication and swallowing disorders, including videofluoroscopy, fiberoptic endoscopic evaluation of swallowing, videostroboscopy, videonasopharyngoscopy, neuromuscular electrical stimulation, and computer technology.
  • Provide services to patients and families or caregivers with hearing loss, including auditory training for patients with cochlear implants and hearing aids and speech and language intervention secondary to hearing loss.
  • Provide assessment and intervention for patients diagnosed with auditory processing disorders.
  • Screen patients for hearing loss or middle-ear pathology using conventional pure-tone air-conduction methods.
  • Modify and enhance communication performance, including accent modification and professional voice care.
  • Comply with hospital and departmental policies and guidelines.
  • Participate in strategic departmental quality-improvement initiatives.
  • Provide education to hospital departments and personnel, students, and outside agencies or schools.
  • Adjust the schedule based on department, patient, and caregiver needs.
  • Determine priorities according to departmental and patient-care needs.
  • Participate in community-based professional events and ongoing educational activities.
  • Support and promote departmental teamwork.
  • Complete mandatory departmental and hospital training on time.
  • Independently perform within department policies and practices, referring complex policy and procedure questions to the Assistant Clinical Manager or Clinical Manager.
  • Independently set professional-development goals.
  • Provide clinical supervision of supportive personnel, Clinical Fellows, and students as required by Rhode Island licensing rules, including cosigning notes and reviewing treatment plans and goals.
Desired Qualifications
  • Membership and involvement in a discipline-specific professional organization or other clinically relevant organization is strongly encouraged.
Brown University Health

Brown University Health

View

Memoir Health provides a behavioral healthcare platform that enables home-based care for behavioral health and substance use issues. It helps health systems remotely manage patients with tools like remote patient monitoring, scheduling, virtual care, and outcomes management, powered by a data analytics engine that highlights cost-saving opportunities and supports automated workflows and one-click referrals. The platform differentiates itself by automating care journeys and delivering integrated, outcomes-focused care within managed care and other healthcare networks, reducing administrative workload for clinicians. Its goal is to make care more proactive, accessible, and coordinated from patients’ homes, improving outcomes while lowering costs, and Memoir Health was later acquired by Lumeo Health in 2020.

Company Size

1-10

Company Stage

Seed

Total Funding

$7.5M

Headquarters

New York City, New York

Founded

2018

Get referred to Brown University Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • A $37 million Starr Foundation alliance launched September 2026 for aging research.
  • Brown Health targets 30,000 new primary-care patients and 27 hires over three years.
  • Primary-care waitlists fell from 14,000 to 4,800, showing access improvements.

What critics are saying

  • UnitedHealthcare Medicare Advantage cutoffs hit 1,900 members in July 2026, hurting referrals.
  • A Massachusetts data breach investigation remains unresolved, exposing patient trust and regulatory risk.
  • Fiscal 2025 margin was 0.9%; weak reimbursement can trigger another existential liquidity squeeze.

What makes Brown University Health unique

  • Brown University Health unites Lifespan hospitals with Brown University academic medicine since 2025.
  • Its 2025 Brown Physicians merger added 500-plus physicians and 1,500-plus providers.
  • Epic, Workday, and Brown-aligned research integration create a larger operating platform.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Holidays

Paid Sick Leave

Productivity Bonus

Stock Options

Company Equity

Conference Attendance Budget

Wellness Program

Mental Health Support

Gym Membership

Phone/Internet Stipend

Home Office Stipend

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Parental Leave

Loan Assistance

Professional Development Budget

Education allowance

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Commuter Benefits

Meal Benefits

Medical Insurance

Life Insurance

Disability Insurance

Company News

Providence Business News
Apr 25th, 2023
Miriam Hospital’s palliative care program is first in R.I. and one of few in U.S.

LIFESPAN CORP. and HopeHealth launched the state’s first palliative care program in the emergency department of The Miriam Hospital.

Providence Business News
Jan 4th, 2023
Markell named New CFO of Lifespan Corp.

PETER K. MARKELL was named Lifespan Corp. ’s new chief financial officer and executive vice president, starting Jan. 30.

Providence Business News
Dec 26th, 2022
Pareek appointed chief of urology for Lifespan hospitals

PROVIDENCE – Lifespan Corp. has appointed Dr. Gyan Pareek as chief of urology in the department of surgery at Lifespan hospitals and president of Brown Urology Inc.

Providence Business News
Dec 15th, 2022
Lifespan Cancer Institute launches career program for young people of color

PROVIDENCE – The Lifespan Cancer Institute is launching a new program to train high school students of color for a career in cancer research and medicine.

Business Wire
Dec 15th, 2022
Trisalus Life Sciences Highlights Pressure-Enabled Regional Immuno-Oncology™ (Perio™) Clinical Trial Progress And Pre-Clinical Research Developments

DENVER & CHICAGO--(BUSINESS WIRE)--TriSalus Life Sciences®, Inc. (“TriSalus” or the “company”), an oncology company in the process of going public through a business combination transaction (the “Business Combination”) with MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or “MTAC”), today announced that it has expanded the reach of its ongoing Pressure-Enabled Regional Immuno-Oncology™ (“PERIO™-01” and “PERIO™-02”) clinical program.In recent months TriSalus has opened five new PERIO™-01 (NCT04935229) clinical trial sites, at Stanford University Hospitals, University of California Los Angeles, University of Colorado’s Anschutz Medical Campus, University of Washington Medical Center and University of Miami’s Sylvester Comprehensive Cancer Center, in addition to five previously activated sites. The PERIO™-01 trial is studying an investigational drug, SD-101, delivered intravascularly by the TriNav® Infusion System (“TriNav®”) using the company’s proprietary Pressure-Enabled Drug Delivery™ (“PEDD™”) method of administration. The study is evaluating whether this platform approach with SD-101 and PEDD™ can improve the performance of systemic checkpoint inhibitors in treating patients with uveal melanoma with liver metastases. In addition to these U.S. sites, TriSalus anticipates opening future PERIO™-01 clinical trial sites in the United Kingdom, Europe, and Canada.In parallel, TriSalus opened PERIO™-02 (NCT05220722) trial sites at Columbia University and University of Colorado Denver, along with Rhode Island Hospital – which was announced last month as part of an expanded research collaboration with Lifespan Health System